Latest SNP genotyping Stories
SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM) today announced that the company's first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched.
CARLSBAD, Calif., Aug.
SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM) today announced the launch of the MassARRAY(R) Compact 96 system.
FREMONT, Calif., July 7 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
The single-nucleotide polymorphism (SNP) known as 2q35-rs13387042 is associated with increased risk of estrogen receptor (ER) -positive and -negative breast cancer, according to a study published online July 1 in the Journal of the National Cancer Institute.
FREMONT, Calif., April 28 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
OMAHA, Neb., April 7 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a leading global biotechnology company, announces that it has completed a licensing option with the Dana-Farber Cancer Institute, Boston, MA with regard to a method known as Cold-PCR.
MOUNTAIN VIEW, Calif., March 10 /PRNewswire/ -- Frost & Sullivan recognizes BioTrove, Inc. with the 2009 North American Frost & Sullivan Award for Growth Strategy Leadership of the Year.
FREMONT, Calif., Feb. 25 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
FREMONT, Calif., Jan. 12 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc.
- To fire mitraille at.